Education
About Us
Working with TipRanks
Follow Us
SenesTech (SNES)
:SNES
Top Page
SenesTech
(NASDAQ:SNES)
Rating:52Neutral
Price Target:
$3.00
▲( 14.50% Upside)
SenesTech (SNES) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$4.65M
Dividend YieldN/A
Average Volume (3M)37.25K
Price to Earnings (P/E)―
Beta (1Y)1.04
Revenue Growth40.15%
EPS Growth94.78%
CountryUS
Employees23
SectorBasic Materials
Sector Strength64
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-1.28
Shares Outstanding1,775,930
10 Day Avg. Volume27,506
30 Day Avg. Volume37,251
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)1.59
Price to Sales (P/S)0.00
P/FCF Ratio-0.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$10.00Price Target Upside281.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
SenesTech Business Overview & Revenue Model
Company DescriptionSenesTech, Inc. is a biotechnology company that focuses on developing sustainable solutions for pest management. The company operates within the sectors of agriculture and pest control, offering innovative products designed to curb rodent populations humanely and effectively. Its flagship product, ContraPest, is a revolutionary rodent fertility control bait that targets the reproductive capabilities of rodents, reducing their population growth over time without harmful side effects on non-target species or the environment.
How the Company Makes MoneySenesTech generates revenue through the sale of its primary product, ContraPest, which is distributed to various sectors, including agriculture, municipalities, and commercial enterprises that require effective rodent management solutions. The company partners with pest management professionals and distribution networks to expand the reach of its product. SenesTech's earnings are influenced by factors such as regulatory approvals, market demand for humane and environmentally friendly pest control solutions, and the expansion of its distribution channels.
SenesTech Financial Statement Overview
Summary
SenesTech shows potential with its revenue growth and stable balance sheet, but continues to face significant challenges in achieving profitability and positive cash flows. The company's financial health is hampered by ongoing net losses and negative cash flow, necessitating a strategic focus on operational efficiency and cost management to improve financial performance.Income Statement
SenesTech has shown some revenue growth, with a significant increase from $1,193,000 in 2023 to $1,857,000 in 2024. However, the company is still struggling with profitability, as evidenced by the negative EBIT and net income. The gross profit margin has improved, but the net profit margin remains non-existent due to zero net income in 2024. These factors result in a moderate score, reflecting positive revenue trends but ongoing profitability challenges.45
Neutral
Balance Sheet
The balance sheet indicates a stable equity position with a decrease in total liabilities over the years. The debt-to-equity ratio is low, showing conservative leverage. However, the return on equity is weak due to persistent net losses, limiting the score to an average level. The company's financial stability is supported by a solid equity base, but profitability issues weigh heavily.50
Neutral
Cash Flow
SenesTech's cash flow statement reveals challenges with negative operating and free cash flows, despite some improvement in free cash flow from 2023 to 2024. The operating cash flow to net income ratio cannot be calculated for 2024 due to zero net income. The company has relied on financing activities to manage cash needs, reflecting ongoing cash flow struggles and reducing the score.40
Negative
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 1.86M | 1.19M | 1.02M | 576.00K | 258.00K | Gross Profit |
| 1.00M | 539.00K | 464.00K | 220.00K | -23.00K | EBIT |
| -6.25M | -7.73M | -9.67M | -8.93M | -7.93M | EBITDA |
| -6.01M | -7.57M | -9.51M | -7.95M | -7.62M | Net Income Common Stockholders |
| -6.18M | -7.71M | -9.71M | -7.98M | -7.70M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 1.31M | 5.39M | 4.78M | 9.33M | 3.64M | Total Assets |
| 3.28M | 7.29M | 6.78M | 11.50M | 6.02M | Total Debt |
| 262.00K | 406.00K | 359.00K | 555.00K | 1.44M | Net Debt |
| -1.04M | -4.99M | -4.42M | -8.77M | -2.20M | Total Liabilities |
| 767.00K | 942.00K | 1.50M | 1.47M | 2.14M | Stockholders Equity |
| 2.51M | 6.35M | 5.28M | 10.04M | 3.88M |
| Cash Flow | Free Cash Flow | |||
| -6.12M | -7.71M | -8.75M | -7.88M | -7.22M | Operating Cash Flow |
| -6.03M | -7.57M | -8.58M | -7.78M | -7.11M | Investing Cash Flow |
| -56.00K | -149.00K | -170.00K | -99.00K | -67.00K | Financing Cash Flow |
| 2.00M | 8.34M | 4.20M | 13.56M | 8.88M |
SenesTech Technical Analysis
Positive
2.62
Price Trends
2.17
Positive
2.61
Positive
2.77
Negative
Market Momentum
0.14
Positive
56.51
Neutral
30.99
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SNES, the sentiment is Positive. The current price of 2.62 is above the 20-day moving average (MA) of 2.57, above the 50-day MA of 2.17, and below the 200-day MA of 2.77, indicating a neutral trend. The MACD of 0.14 indicates Positive momentum. The RSI at 56.51 is Neutral, neither overbought nor oversold. The STOCH value of 30.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SNES.
SenesTech Risk Analysis
SenesTech disclosed 33 risk factors in its most recent earnings report. SenesTech reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
SenesTech Peers Comparison
Overall Rating
UnderperformOutperform
Sector (50)
Financial Indicators
Performance Comparison
SNES
SenesTech
2.75
-4.65
-62.84%
ITP
IT Tech Packaging
0.20
-0.05
-20.00%
BHILQ
Benson Hill
0.05
-6.77
-99.27%
SenesTech Earnings Call Summary
Earnings Call Date:May 08, 2025
(Q1-2025)
| % Change Since: 4.80%|
Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment Positive
The company showed strong growth in its Evolve product line and significant progress in municipal and international markets, with improved gross margins and operational efficiencies. However, challenges remain in brick and mortar retail expansion and international sales recognition.Q1-2025 Updates
Positive Updates
Evolve Product Line Expansion
Evolve revenue grew 40% compared to the previous year, with gross margins increasing to nearly 65%, up from 33%, resulting in a 132% increase in gross profit.
Municipal and Ecommerce Growth
Significant deployments in major U.S. cities like Chicago and New York. Ecommerce sales increased by 107% over the last year.
International Market Expansion
Agreements signed for distribution in 12 countries, with commercial shipments occurring in Hong Kong, UAE, Maldives, and Netherlands.
Operational Efficiency Improvements
Implemented initiatives to reduce expenses by $2 million annually, lowering the revenue threshold for cash flow breakeven to $1.5 million quarterly.
Record Gross Profit
Gross profit for the first quarter was the highest in the company's history due to the launch of Evolve.
Negative Updates
Brick and Mortar Retail Challenges
Limited progress in achieving shelf space in brick and mortar retail, with growth primarily dependent on ecommerce performance.
No Recognized International Sales in Q1
Awaiting follow-on orders from international markets, with no recognized international sales during Q1.
Company Guidance
During the SenesTech First Quarter Fiscal Year 2025 Financial Results Conference Call, the company reported significant progress with its Evolve product line, which now accounts for 79% of first-quarter sales and has driven a 40% increase in revenue compared to the same period last year. Evolve's success has led to gross margins rising to a record 65%, up from 33% the previous year, contributing to a 132% increase in gross profit dollars. The company has expanded its presence through ecommerce, municipal deployments, and international markets, with ecommerce sales up 107% year-over-year, now making up 61% of their total sales. Municipal sales have seen a sevenfold increase, with deployments in major U.S. cities like Chicago and New York. The company has also signed distribution agreements in 12 countries and territories, with shipments planned for markets including Australia and New Zealand. Operational optimizations have reduced the cash flow breakeven threshold to $1.5 million in quarterly revenue, down from $12 million annually. Despite challenges in brick-and-mortar retail, SenesTech's focus on high-margin Evolve products and cost-reduction initiatives positions it for future growth and profitability.SenesTech Corporate Events
Private Placements and Financing
SenesTech Secures $1.1M Through Warrant Agreements
Neutral
Mar 11, 2025
On March 9, 2025, SenesTech entered into agreements with holders of existing warrants to exercise their rights at a reduced price, generating approximately $1.1 million in gross proceeds. The company will issue new short-term warrants, potentially bringing in an additional $4.3 million if fully exercised, with the proceeds intended for working capital and general corporate purposes. The transactions are facilitated by H.C. Wainwright & Co., LLC, and are subject to customary closing conditions and stockholder approval. The new warrants are unregistered and will expire eighteen months after stockholder approval, with no active trading market expected for them.
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.